Gut microbiome diversity is an independent predictor of survival in cervical cancer patients receiving chemoradiation
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Gut microbiome diversity is an independent predictor of survival in cervical cancer patients receiving chemoradiation
Authors
Keywords
-
Journal
Communications Biology
Volume 4, Issue 1, Pages -
Publisher
Springer Science and Business Media LLC
Online
2021-02-22
DOI
10.1038/s42003-021-01741-x
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Microbial Diversity and Composition Is Associated with Patient-Reported Toxicity during Chemoradiation Therapy for Cervical Cancer
- (2020) Aparna Mitra et al. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
- Cancer statistics, 2019
- (2019) Rebecca L. Siegel et al. CA-A CANCER JOURNAL FOR CLINICIANS
- The microbiome, cancer, and cancer therapy
- (2019) Beth A. Helmink et al. NATURE MEDICINE
- Modulating the microbiome to improve therapeutic response in cancer
- (2019) Jennifer L McQuade et al. LANCET ONCOLOGY
- Assessing the interactions between radiotherapy and antitumour immunity
- (2019) Clemens Grassberger et al. Nature Reviews Clinical Oncology
- Trends in cervical cancer incidence rates by age, race/ethnicity, histological subtype, and stage at diagnosis in the United States
- (2019) Farhad Islami et al. PREVENTIVE MEDICINE
- Radiation therapy and anti-tumor immunity: exposing immunogenic mutations to the immune system
- (2019) Claire Lhuillier et al. Genome Medicine
- Gut microbial diversity and genus-level differences identified in cervical cancer patients versus healthy controls
- (2019) Travis T. Sims et al. GYNECOLOGIC ONCOLOGY
- Kinetics of intratumoral immune cell activation during chemoradiation for cervical cancer
- (2018) Stephanie Dorta-Estremera et al. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
- Targeting friend and foe: Emerging therapeutics in the age of gut microbiome and disease
- (2018) Jin Ah Cho et al. JOURNAL OF MICROBIOLOGY
- Temporal development of the gut microbiome in early childhood from the TEDDY study
- (2018) Christopher J. Stewart et al. NATURE
- The microbiota: an underestimated actor in radiation-induced lesions?
- (2017) Harry Sokol et al. GUT
- Radiation induces proinflammatory dysbiosis: transmission of inflammatory susceptibility by host cytokine induction
- (2017) Shiran Gerassy-Vainberg et al. GUT
- Systematic Review
- (2017) Ann Muls et al. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER
- Assessment of variation in microbial community amplicon sequencing by the Microbiome Quality Control (MBQC) project consortium
- (2017) Rashmi Sinha et al. NATURE BIOTECHNOLOGY
- Gut microbiota modulation of chemotherapy efficacy and toxicity
- (2017) James L. Alexander et al. Nature Reviews Gastroenterology & Hepatology
- Gut microbiome modulates response to anti–PD-1 immunotherapy in melanoma patients
- (2017) V. Gopalakrishnan et al. SCIENCE
- Impact of (chemo)radiotherapy on immune cell composition and function in cervical cancer patients
- (2017) H. van Meir et al. OncoImmunology
- The role of adiponectin in obesity-associated female-specific carcinogenesis
- (2016) Ganji Purnachandra Nagaraju et al. CYTOKINE & GROWTH FACTOR REVIEWS
- The association between BMI and cervical cancer risk
- (2016) Jalal Poorolajal et al. EUROPEAN JOURNAL OF CANCER PREVENTION
- Composition and temporal stability of the gut microbiota in older persons
- (2015) Ian B Jeffery et al. ISME Journal
- The Impact of Body Mass Index on the Surgical Outcomes of Patients With Gastric Cancer
- (2015) Hai-Ning Chen et al. MEDICINE
- Commensal Bifidobacterium promotes antitumor immunity and facilitates anti-PD-L1 efficacy
- (2015) A. Sivan et al. SCIENCE
- Gut microbes of mammalian herbivores facilitate intake of plant toxins
- (2014) Kevin D. Kohl et al. ECOLOGY LETTERS
- The impact of obesity on surgical staging, complications, and survival with uterine cancer: A Gynecologic Oncology Group LAP2 ancillary data study
- (2014) Camille C. Gunderson et al. GYNECOLOGIC ONCOLOGY
- Healthy obese versus unhealthy lean: the obesity paradox
- (2014) Carl J. Lavie et al. Nature Reviews Endocrinology
- UPARSE: highly accurate OTU sequences from microbial amplicon reads
- (2013) Robert C Edgar NATURE METHODS
- Impact of Pelvic Radiotherapy on Gut Microbiota of Gynecological Cancer Patients Revealed by Massive Pyrosequencing
- (2013) Young-Do Nam et al. PLoS One
- Interactions Between the Microbiota and the Immune System
- (2012) L. V. Hooper et al. SCIENCE
- Metagenomic biomarker discovery and explanation
- (2011) Nicola Segata et al. GENOME BIOLOGY
- Breast and cervical cancer screening in Spain and predictors of adherence
- (2010) Rocío Martín-López et al. EUROPEAN JOURNAL OF CANCER PREVENTION
- Therapeutic effects of ablative radiation on local tumor require CD8+ T cells: changing strategies for cancer treatment
- (2009) Y. Lee et al. BLOOD
- Fractionated but Not Single-Dose Radiotherapy Induces an Immune-Mediated Abscopal Effect when Combined with Anti-CTLA-4 Antibody
- (2009) M. Z. Dewan et al. CLINICAL CANCER RESEARCH
- Laparoscopy Compared With Laparotomy for Comprehensive Surgical Staging of Uterine Cancer: Gynecologic Oncology Group Study LAP2
- (2009) Joan L. Walker et al. JOURNAL OF CLINICAL ONCOLOGY
- The Gut Microbiota Predispose to the Pathophysiology of Acute Postradiotherapy Diarrhea
- (2008) Chaysavanh Manichanh et al. AMERICAN JOURNAL OF GASTROENTEROLOGY
- Human Leukocyte Antigen Class I, MHC Class I Chain-Related Molecule A, and CD8+/Regulatory T-Cell Ratio: Which Variable Determines Survival of Cervical Cancer Patients?
- (2008) E. S. Jordanova et al. CLINICAL CANCER RESEARCH
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started